WallStreetZenWallStreetZen

NASDAQ: CING
Cingulate Inc Stock

$1.35+0.14 (+11.57%)
Updated Feb 29, 2024
CING Price
$1.35
Fair Value Price
-$0.02
Market Cap
$1.26M
52 Week Low
$1.00
52 Week High
$38.20
P/E
-0.04x
P/B
-13.08x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$21.21M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-61.94
Operating Cash Flow
-$17M
Beta
0.84
Next Earnings
Mar 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CING Overview

Cingulate Inc. is a clinical-stage biopharmaceutical company developing treatments for attention deficit/hyperactivity disorder. The company's lead candidates are CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine). CTx-2103 is being developed for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, KS.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CING scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CING ($1.35) is overvalued by 9,047.11% relative to our estimate of its Fair Value price of -$0.02 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CING ($1.35) is not significantly undervalued (9,047.11%) relative to our estimate of its Fair Value price of -$0.02 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CING is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CING due diligence checks available for Premium users.

Be the first to know about important CING news, forecast changes, insider trades & much more!

CING News

Valuation

CING fair value

Fair Value of CING stock based on Discounted Cash Flow (DCF)
Price
$1.35
Fair Value
-$0.02
Undervalued by
9,080.37%
CING ($1.35) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CING ($1.35) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CING is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CING price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.04x
Industry
14.26x
Market
35.21x

CING price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-13.08x
Industry
6x

CING's financial health

Profit margin

Revenue
$0.0
Net Income
-$6.0M
Profit Margin
0%
CING's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$5.9M
Liabilities
$6.0M
Debt to equity
-61.94
CING's short-term liabilities ($5.73M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CING's short-term assets ($2.90M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CING's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CING's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.3M
Investing
$0.0
Financing
$5.9M
CING's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CING vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
CING$1.26M+11.16%-0.04x-13.08x
AMPE$1.29M-32.61%-0.14x0.24x
ZVSA$1.37M+10.00%-0.01x0.07x
TENX$1.37M+10.87%-0.05x0.12x
ATNF$1.38M+11.75%-0.01x-9.27x

Cingulate Stock FAQ

What is Cingulate's quote symbol?

(NASDAQ: CING) Cingulate trades on the NASDAQ under the ticker symbol CING. Cingulate stock quotes can also be displayed as NASDAQ: CING.

If you're new to stock investing, here's how to buy Cingulate stock.

What is the 52 week high and low for Cingulate (NASDAQ: CING)?

(NASDAQ: CING) Cingulate's 52-week high was $38.20, and its 52-week low was $1.00. It is currently -96.48% from its 52-week high and 34.5% from its 52-week low.

How much is Cingulate stock worth today?

(NASDAQ: CING) Cingulate currently has 937,000 outstanding shares. With Cingulate stock trading at $1.35 per share, the total value of Cingulate stock (market capitalization) is $1.26M.

Cingulate stock was originally listed at a price of $89.00 in Dec 8, 2021. If you had invested in Cingulate stock at $89.00, your return over the last 2 years would have been -98.49%, for an annualized return of -87.71% (not including any dividends or dividend reinvestments).

How much is Cingulate's stock price per share?

(NASDAQ: CING) Cingulate stock price per share is $1.35 today (as of Feb 29, 2024).

What is Cingulate's Market Cap?

(NASDAQ: CING) Cingulate's market cap is $1.26M, as of Mar 1, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cingulate's market cap is calculated by multiplying CING's current stock price of $1.35 by CING's total outstanding shares of 937,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.